Metabolomics in noninvasive breast cancer

Clinica Chimica Acta

Volumn 424, Issue , 2013, Pages 3-7

  Zhang, Ai Hua ^a,b   Sun, Hui ^a,b   Qiu, Shi ^a,b   Wang, Xi Jun ^a,b  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^b Key Pharmacometabolomics Platform of Chinese Medicines   (China)

Author keywords

Biomarkers; Breast cancer; Early diagnosis; Metabolites; Metabolomics

Indexed keywords

4 HYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; TUMOR MARKER; UREA;

BLOOD ANALYSIS; BREAST CANCER; CANCER PROGNOSIS; CANCER RESEARCH; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; MOLECULAR DIAGNOSIS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; URINALYSIS;

BIOMARKERS; BREAST CANCER; EARLY DIAGNOSIS; METABOLITES; METABOLOMICS;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTIDINE MONOPHOSPHATE; EARLY DIAGNOSIS; FATTY ACIDS; FEMALE; GLYCEROPHOSPHATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOMICS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84878376957     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.05.003     Document Type: Review

References (54)

1. Bos P.D., Zhang X.H., Nadal C., Shu W., Gomis R.R., Nguyen D.X., et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459(7249):1005-1009.
2. Shi L. Racial differences in breast cancer patterns. Science 2010, 329:5987.
3. Possemato R., Marks K.M., Shaul Y.D., Pacold M.E., Kim D., Birsoy K., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476(7360):346-350.
4. Genetics Couzin J. DNA test for breast cancer risk draws criticism. Science 2008, 322(5900):357.
5. Locasale J.W., Grassian A.R., Melman T., Lyssiotis C.A., Mattaini K.R., Bass A.J., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011, 43(9):869-874.
6. Perez E.A. Breast cancer management: opportunities and barriers to an individualized approach. Oncologist 2011, 16(Suppl. 1):20-22.
7. Tenori L., Oakman C., Claudino W.M., Bernini P., Cappadona S., Nepi S., et al. Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study. Mol Oncol 2012, 6(4):437-444.
8. Klawitter J., Klawitter J., Gurshtein J., Corby K., Fong S., Tagliaferri M., et al. Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study. Int J Cancer 2011, 129(12):2945-2957.
9. Zhang A., Sun H., Wu X., Wang X. Urine metabolomics. Clin Chim Acta 2012, 414:65-69.
10. Arakaki A.K., Skolnick J., McDonald J.F. Marker metabolites can be therapeutic targets as well. Nature 2008, 456:443.
11. Zhang A., Sun H., Yan G., Han Y., Ye Y., Wang X. Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry. Clin Chim Acta 2013, 418:86-90.
12. Zhang A., Sun H., Han Y., Yuan Y., Wang P., Song G., et al. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012, 137(18):4200-4208.
13. Yuan M., Breitkopf S.B., Yang X., Asara J.M. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 2012, 7:872-881.
14. Nicholson J.K., Wilson I.D. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev 2003, 2:668-676.
15. Chen F., Xue J., Zhou L., Wu S., Chen Z. Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method. Anal Bioanal Chem 2011, 401(6):1899-1904.
16. Sun H., Zhang A., Yan G., Piao C., Li W., Sun C., et al. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 2013, 12(3):710-719.
17. Patterson A.D., Maurhofer O., Beyoglu D., Lanz C., Krausz K.W., Pabst T., et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 2011, 71(21):6590-6600.
18. Zhang A., Sun H., Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol 2012, 168(6):1718-1727.
19. Wang X., Zhang A., Sun H. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 2013, 57(5):2072-2077.
20. Asiago V.M., Alvarado L.Z., Shanaiah N., Gowda G.A., Owusu-Sarfo K., Ballas R.A., et al. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 2010, 70(21):8309-8318.
21. Fukushima A., Kusano M., Nakamichi N., Kobayashi M., Hayashi N., Sakakibara H., et al. Impact of clock-associated Arabidopsis pseudo-response regulators in metabolic coordination. Proc Natl Acad Sci U S A 2009, 106:7251-7256.
22. Catchpole G.S., Beckmann M., Enot D.P., Mondhe M., Zywicki B., Taylor J., et al. Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc Natl Acad Sci U S A 2009, 102:14458-14462.
23. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
24. Wang X., Zhang A., Han Y., Wang P., Sun H., Song G., et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012, 11(8):370-380.
25. Gu H., Pan Z., Xi B., Asiago V., Musselman B., Raftery D. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. Anal Chim Acta 2011, 686(1-2):57-63.
26. Malet-Martino M., Holzgrabe U. NMR techniques in biomedical and pharmaceutical analysis. J Pharm Biomed Anal 2011, 55(1):1-15.
27. Weljie A.M., Bondareva A., Zang P., Jirik F.R. (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. J Biomol NMR 2011, 49(3-4):185-193.
28. Oakman C., Tenori L., Biganzoli L., Santarpia L., Cappadona S., Luchinat C., et al. Uncovering the metabolomic fingerprint of breast cancer. Int J Biochem Cell Biol 2011, 43(7):1010-1020.
29. Vermeer L.S., Fruhwirth G.O., Pandya P., Ng T., Mason A.J. NMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation. J Proteome Res 2012, 11(5):2996-3003.
30. Zhang A., Sun H., Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 2012, 404(4):1239-1245.
31. Bailey S.T., Shin H., Westerling T., Liu X.S., Brown M. Estrogen receptor prevents p53-dependent apoptosis in breast cancer. Proc Natl Acad Sci U S A 2012, 109(44):18060-18065.
32. Klawitter J., Shokati T., Moll V., Christians U., Klawitter J. Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. Breast Cancer Res 2010, 12(2):R16.
33. Sitter B., Bathen T.F., Singstad T.E., Fjøsne H.E., Lundgren S., Halgunset J., et al. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 2010, 23(4):424-431.
34. Kleiner M., Wentrup C., Lott C., Teeling H., Wetzel S., Young J., et al. Metaproteomics of a gutless marine worm and its symbiotic microbial community reveal unusual pathways for carbon and energy use. Proc Natl Acad Sci U S A 2012, 109(19):E1173-E1182.
35. Rivas-Ubach A., Sardans J., Pérez-Trujillo M., Estiarte M., Peñuelas J. Strong relationship between elemental stoichiometry and metabolome in plants. Proc Natl Acad Sci U S A 2012, 109(11):4181-4186.
36. Wu R., Wu Z., Wang X., Yang P., Yu D., Zhao C., et al. Metabolomic analysis reveals that carnitines are key regulatory metabolites in phase transition of the locusts. Proc Natl Acad Sci U S A 2012, 109(9):3259-3263.
37. Finley L.W., Lee J., Souza A., Desquiret-Dumas V., Bullock K., Rowe G.C., et al. Skeletal muscle transcriptional coactivator PGC-1α mediates mitochondrial, but not metabolic, changes during calorie restriction. Proc Natl Acad Sci U S A 2012, 109(8):2931-2936.
38. Mintz-Oron S., Meir S., Malitsky S., Ruppin E., Aharoni A., Shlomi T. Reconstruction of Arabidopsis metabolic network models accounting for subcellular compartmentalization and tissue-specificity. Proc Natl Acad Sci U S A 2012, 109(1):339-344.
39. Lange B.M., Mahmoud S.S., Wildung M.R., Turner G.W., Davis E.M., Lange I., et al. Improving peppermint essential oil yield and composition by metabolic engineering. Proc Natl Acad Sci U S A 2011, 108(41):16944-16949.
40. Ward J.L., Baker J.M., Llewellyn A.M., Hawkins N.D., Beale M.H. Metabolomic analysis of Arabidopsis reveals hemiterpenoid glycosides as products of a nitrate ion-regulated, carbon flux overflow. Proc Natl Acad Sci U S A 2011, 108(26):10762-10767.
41. Kim Y., Koo I., Jung B.H., Chung B.C., Lee D. Multivariate classification of urine metabolome profiles for breast cancer diagnosis. BMC Bioinformatics 2010, 11(Suppl.2):S4.
42. Nam H., Chung B.C., Kim Y., Lee K., Lee D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 2009, 25(23):3151-3157.
43. Henneges C., Bullinger D., Fux R., Friese N., Seeger H., Neubauer H., et al. Prediction of breast cancer by profiling of urinary RNA metabolites using support vector machine-based feature selection. BMC Cancer 2009, 9:104.
44. Budczies J., Denkert C., Müller B.M., Brockmöller S.F., Klauschen F., Györffy B., et al. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study. BMC Genomics 2012, 13:334.
45. Brockmöller S.F., Bucher E., Müller B.M., Budczies J., Hilvo M., Griffin J.L., et al. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res 2012, 11(2):850-860.
46. Li M., Song Y., Cho N., Chang J.M., Koo H.R., Yi A., et al. An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy. PLoS One 2011, 6(10):e25563.
47. Giskeødegård G.F., Lundgren S., Sitter B., Fjøsne H.E., Postma G., Buydens L.M., et al. Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR Biomed 2012, 25(11):1271-1279.
48. Slupsky C.M., Steed H., Wells T.H., Dabbs K., Schepansky A., Capstick V., et al. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin Cancer Res 2010, 16(23):5835-5841.
49. Oakman C., Tenori L., Claudino W.M., Cappadona S., Nepi S., Battaglia A., et al. Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods. Ann Oncol 2011, 22(6):1295-1301.
50. Simpson N.E., Tryndyak V.P., Beland F.A., Pogribny I.P. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression. Breast Cancer Res Treat 2012, 133(3):959-968.
51. Woo H.M., Kim K.M., Choi M.H., Jung B.H., Lee J., Kong G., et al. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta 2009, 400(1-2):63-69.
52. Chen Y., Zhang R., Song Y., He J., Sun J., Bai J. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer. Analyst 2009, 134(10):2003-2011.
53. Nomura D.K., Dix M.M., Cravatt B.F. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 2010, 10(9):630-638.
54. Tomita M., Kami K. Cancer. Systems biology, metabolomics, and cancer metabolism. Science 2012, 336(6084):990-991.